Literature DB >> 29532456

Association of HSP22 with mTOR in osteoblasts: regulation of TNF-α-stimulated IL-6 synthesis.

Go Sakai1,2, Haruhiko Tokuda2,3, Naohiro Yamamoto1,2, Rie Matsushima-Nishiwaki2, Kazuhiko Fujita1,2, Tetsu Kawabata1,2, Osamu Kozawa2, Takanobu Otsuka1.   

Abstract

Heat shock protein 22 (HSP22) is ubiquitously expressed in various types of cells including in osteoblasts. We previously reported that tumor necrosis factor (TNF)-α stimulates interleukin (IL)-6 synthesis via p44/p42 MAPK in osteoblast-like MC3T3-E1 cells and that mTOR/p70 S6 kinase (p70 S6K) negatively regulates the IL-6 synthesis. In this study, we investigated the involvement of HSP22 in TNF-α-stimulated-IL-6 synthesis and the underlying mechanism in MC3T3-E1 cells. HSP22 knockdown reduces TNF-α-stimulated release of IL-6. In addition, HSP22 knockdown strengthens TNF-α-induced phosphorylation of p70 S6K but suppresses that of p44/p42 MAPK. HSP22 coimmunoprecipitates with mTOR. HSP22 knockdown increases the basal levels of phosphorylated mTOR. These results strongly suggest that HSP22 interacts with mTOR and regulates TNF-α-induced IL-6 synthesis in osteoblasts.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990mTORzzm321990; HSP22; osteoblast

Mesh:

Substances:

Year:  2018        PMID: 29532456     DOI: 10.1002/1873-3468.13028

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  HSP22 (HSPB8) positively regulates PGF2α-induced synthesis of interleukin-6 and vascular endothelial growth factor in osteoblasts.

Authors:  Gen Kuroyanagi; Go Sakai; Takanobu Otsuka; Naohiro Yamamoto; Kazuhiko Fujita; Tetsu Kawabata; Rie Matsushima-Nishiwaki; Osamu Kozawa; Haruhiko Tokuda
Journal:  J Orthop Surg Res       Date:  2021-01-21       Impact factor: 2.359

2.  Hsp22 ameliorates lipopolysaccharide-induced myocardial injury by inhibiting inflammation, oxidative stress, and apoptosis.

Authors:  Yun Yu; Long-Long Hu; Liang Liu; Ling-Ling Yu; Jun-Pei Li; Jing-An Rao; Ling-Juan Zhu; Hui-Hui Bao; Xiao-Shu Cheng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.